{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:44:26Z","timestamp":1772793866319,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2010\/18380\u20136"],"award-info":[{"award-number":["2010\/18380\u20136"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.vph.2021.106880","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T13:31:49Z","timestamp":1622122309000},"page":"106880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Chronic cyclooxygenase-2 inhibition prevents the worsening of hypertension and endothelial dysfunction induced by ouabain in resistance arteries of spontaneously hypertensive rats"],"prefix":"10.1016","volume":"139","author":[{"given":"Helane Tito","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisele Kruger","family":"Couto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Davel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiano Elias","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Venturini","family":"Rossoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5893","key":"10.1016\/j.vph.2021.106880_bb0005","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/300650a0","article-title":"A circulating inhibitor of (Na+ + K+)ATPase associated with essential hypertension","volume":"300","author":"Hamlyn","year":"1982","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.vph.2021.106880_bb0010","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1073\/pnas.88.14.6259","article-title":"Identification and characterization of a ouabain-like compound from human plasma","volume":"88","author":"Hamlyn","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6 Pt 1","key":"10.1016\/j.vph.2021.106880_bb0015","first-page":"C1367","article-title":"Physiological effects of endogenous ouabain: control of intracellular Ca2+ stores and cell responsiveness","volume":"264","author":"Blaustein","year":"1993","journal-title":"Am. J. Phys."},{"issue":"5","key":"10.1016\/j.vph.2021.106880_bb0020","doi-asserted-by":"crossref","first-page":"H1031","DOI":"10.1152\/ajpheart.00899.2011","article-title":"How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension","volume":"302","author":"Blaustein","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2021.106880_bb0025","doi-asserted-by":"crossref","first-page":"102159","DOI":"10.1016\/j.ceca.2020.102159","article-title":"Ouabain, endogenous ouabain and ouabain-like factors: the Na+ pump\/ouabain receptor, its linkage to NCX, and its myriad functions","volume":"86","author":"Blaustein","year":"2020","journal-title":"Cell Calcium"},{"issue":"3","key":"10.1016\/j.vph.2021.106880_bb0030","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/01.HYP.34.3.450","article-title":"Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension","volume":"34","author":"Manunta","year":"1999","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.vph.2021.106880_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0895-7061(00)01225-5","article-title":"Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension","volume":"14","author":"Pierdomenico","year":"2001","journal-title":"Am. J. Hypertens."},{"issue":"7","key":"10.1016\/j.vph.2021.106880_bb0040","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3390\/ijms19071948","article-title":"Endogenous Ouabain and related genes in the translation from hypertension to renal diseases","volume":"19","author":"Simonini","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.vph.2021.106880_bb0045","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.HYP.22.2.178","article-title":"Long-term ouabain administration produces hypertension in rats","volume":"22","author":"Yuan","year":"1993","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.vph.2021.106880_bb0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00004872-199405000-00008","article-title":"Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure","volume":"12","author":"Manunta","year":"1994","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.vph.2021.106880_bb0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.HYP.34.1.107","article-title":"Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats","volume":"34","author":"Huang","year":"1999","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.vph.2021.106880_bb0060","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bjp.0704501","article-title":"Alterations in phenylephrine-induced contractions and the vascular expression of Na+,K+-ATPase in ouabain-induced hypertension","volume":"135","author":"Rossoni","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.vph.2021.106880_bb0065","doi-asserted-by":"crossref","first-page":"H2110","DOI":"10.1152\/ajpheart.00454.2002","article-title":"Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors","volume":"283","author":"Rossoni","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.vph.2021.106880_bb0070","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00004872-200304000-00018","article-title":"Chronic peripheral ouabain treatment affects the brain endothelin system of rats","volume":"21","author":"Di Filippo","year":"2003","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.vph.2021.106880_bb0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bjp.0705919","article-title":"Ouabain-induced hypertension alters the participation of endothelial factors in alpha-adrenergic responses differently in rat resistance and conductance mesenteric arteries","volume":"143","author":"Xavier","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.vph.2021.106880_bb0080","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/sj.bjp.0705994","article-title":"Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain","volume":"143","author":"Xavier","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.vph.2021.106880_bb0085","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/00004872-200405000-00017","article-title":"Neurogenic nitric oxide release increases in mesenteric arteries from ouabain hypertensive rats","volume":"22","author":"Xavier","year":"2004","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.vph.2021.106880_bb0090","doi-asserted-by":"crossref","first-page":"H193","DOI":"10.1152\/ajpheart.00802.2005","article-title":"Alterations in structure and mechanics of resistance arteries from ouabain-induced hypertensive rats","volume":"291","author":"Briones","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.vph.2021.106880_bb0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/HJH.0b013e328317a7cf","article-title":"Activation of BKCa channels by nitric oxide prevents coronary artery endothelial dysfunction in ouabain-induced hypertensive rats","volume":"27","author":"Briones","year":"2009","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.vph.2021.106880_bb0100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000322576","article-title":"Long-term ouabain treatment impairs vascular function in resistance arteries","volume":"48","author":"Wenceslau","year":"2011","journal-title":"J. Vasc. Res."},{"issue":"2","key":"10.1016\/j.vph.2021.106880_bb0105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/FJC.0b013e3182955d33","article-title":"Increased constrictor tone induced by ouabain treatment in rats","volume":"62","author":"Pulgar","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.vph.2021.106880_bb0110","first-page":"113","article-title":"Enhanced Na+, K+-ATPase activity and endothelial modulation decrease phenylephrine-induced contraction in aorta from ouabain-treated normotensive and hypertensive rats","volume":"18","author":"Davel","year":"2014","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"issue":"6","key":"10.1016\/j.vph.2021.106880_bb0115","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/HJH.0b013e32832a391f","article-title":"Chronic ouabain treatment exacerbates blood pressure elevation in spontaneously hypertensive rats: the role of vascular mechanisms","volume":"27","author":"Xavier","year":"2009","journal-title":"J. Hypertens."},{"issue":"3\u20134","key":"10.1016\/j.vph.2021.106880_bb0120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1515\/JBCPP.1995.6.3-4.309","article-title":"Ouabain amplifies contractile responses to phenylephrine in rat tail arteries in hypertension","volume":"6","author":"Songu-Mize","year":"1995","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2021.106880_bb0125","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1590\/S0100-879X1997000400016","article-title":"Effects of ouabain on vascular reactivity","volume":"30","author":"Vassallo","year":"1997","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"8","key":"10.1016\/j.vph.2021.106880_bb0130","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1590\/S0100-879X2001000800014","article-title":"Effects of small doses of ouabain on the arterial blood pressure of anesthetized hypertensive and normotensive rats","volume":"34","author":"Rossoni","year":"2001","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"3","key":"10.1016\/j.vph.2021.106880_bb0135","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/01.fjc.0000138165.96364.51","article-title":"Ouabain at nanomolar concentration promotes synthesis and release of angiotensin II from the endothelium of the tail vascular bed of spontaneously hypertensive rats","volume":"44","author":"Padilha","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.vph.2021.106880_bb0140","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/HJH.0000000000000059","article-title":"Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase\/cSRC pathway","volume":"32","author":"Wenceslau","year":"2014","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.vph.2021.106880_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","article-title":"Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats","volume":"41","author":"Mulvany","year":"1977","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.vph.2021.106880_bb0150","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.lfs.2003.07.002","article-title":"Cyclooxygenase pathway is involved in the vascular reactivity and inhibition of the Na+, K+-ATPase activity in the tail artery from L-NAME-treated rats","volume":"74","author":"dos Santos","year":"2003","journal-title":"Life Sci."},{"issue":"1\u20133","key":"10.1016\/j.vph.2021.106880_bb0155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2008.10.023","article-title":"Ouabain treatment changes the role of endothelial factors in rat resistance arteries","volume":"600","author":"Padilha","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.vph.2021.106880_bb0160","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/bjp.2008.200","article-title":"Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin","volume":"154","author":"Xavier","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"27","key":"10.1016\/j.vph.2021.106880_bb0165","doi-asserted-by":"crossref","first-page":"19323","DOI":"10.1074\/jbc.274.27.19323","article-title":"Intracellular reactive oxygen species mediate the linkage of Na+\/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes","volume":"274","author":"Xie","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.vph.2021.106880_bb0170","doi-asserted-by":"crossref","first-page":"18694","DOI":"10.1074\/jbc.M111357200","article-title":"Src-mediated inter-receptor cross-talk between the Na+\/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases","volume":"277","author":"Haas","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.vph.2021.106880_bb0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mi.3.3.157","article-title":"Na+-K+--ATPase-mediated signal transduction: from protein interaction to cellular function","volume":"3","author":"Xie","year":"2003","journal-title":"Mol. Interv."},{"issue":"32","key":"10.1016\/j.vph.2021.106880_bb0180","doi-asserted-by":"crossref","first-page":"33306","DOI":"10.1074\/jbc.M402187200","article-title":"Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238","volume":"279","author":"Ferrandi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2021.106880_bb0185","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.2741\/1766","article-title":"The Na\/K-ATPase-mediated signal transduction as a target for new drug development","volume":"10","author":"Xie","year":"2005","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.vph.2021.106880_bb0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jnr.22745","article-title":"Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-\u03baB in the rat hippocampus","volume":"90","author":"Kawamoto","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.vph.2021.106880_bb0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neuropharm.2013.06.006","article-title":"Ouabain activates NF\u03baB through an NMDA signaling pathway in cultured cerebellar cells","volume":"73","author":"de S\u00e1","year":"2013","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.vph.2021.106880_bb0200","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1476-5381.2011.01276.x","article-title":"Endothelium-mediated control of vascular tone: COX-1 and COX-2 products","volume":"164","author":"F\u00e9l\u00e9tou","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2021.106880_bb0205","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.RES.0000138300.41642.15","article-title":"Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration","volume":"95","author":"Ashton","year":"2004","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.vph.2021.106880_bb0210","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bcp.2009.04.022","article-title":"Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of rho kinase","volume":"78","author":"Liu","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.vph.2021.106880_bb0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejphar.2017.09.028","article-title":"Antagonist of thromboxane A2 receptor by SQ29548 lowers DOCA-induced hypertension in diabetic rats","volume":"815","author":"Sun","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2021.106880_bb0220","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/10641963.2016.1246558","article-title":"Activation of thromboxane A2 receptors mediates endothelial dysfunction in diabetic mice","volume":"39","author":"Xie","year":"2017","journal-title":"Clin. Exp. Hypertens."},{"issue":"1","key":"10.1016\/j.vph.2021.106880_bb0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(98)00278-7","article-title":"Effect of Na+ on Na+,K+-ATPase alpha-subunit expression and Na+\u2212pump activity in aortic smooth muscle cells","volume":"351","author":"Liu","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl","key":"10.1016\/j.vph.2021.106880_bb0230","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1291\/hypres.23.Supplement_S55","article-title":"Differential regulation of the sodium pump alpha-subunit isoform gene by ouabain and digoxin in tissues of rats","volume":"23","author":"Wang","year":"2000","journal-title":"Hypertens. Res."},{"issue":"23","key":"10.1016\/j.vph.2021.106880_bb0235","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1073\/pnas.221315298","article-title":"Ouabain, a steroid hormone that signals with slow calcium oscillations","volume":"98","author":"Aizman","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.vph.2021.106880_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197688","article-title":"Na\/K-ATPase signaling mediates miR-29b-3p regulation and cardiac fibrosis formation in mice with chronic kidney disease","volume":"13","author":"Drummond","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vph.2021.106880_bb0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-5793(95)01301-6","article-title":"Stimulatory effect of ouabain on VCAM-1 and iNOS expression in murine endothelial cells: involvement of NF-kappa B","volume":"377","author":"Bereta","year":"1995","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.vph.2021.106880_bb0250","first-page":"E83","article-title":"The transcription factor NF-kappa B and the regulation of vascular cell function","volume":"20","author":"De Martin","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2021.106880_bb0255","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12974-014-0218-z","article-title":"Signaling function of Na,K-ATPase induced by ouabain against LPS as an inflammation model in hippocampus","volume":"11","author":"Kinoshita","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.vph.2021.106880_bb0260","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1038\/s41598-017-05075-9","article-title":"Alpha 2 Na+,K+-ATPase silencing induces loss of inflammatory response and ouabain protection in glial cells","volume":"7","author":"Kinoshita","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.vph.2021.106880_bb0265","doi-asserted-by":"crossref","first-page":"H613","DOI":"10.1152\/ajpheart.00144.2010","article-title":"Inducible nitric oxide synthase gene deletion exaggerates MAPK-mediated cyclooxygenase-2 induction by inflammatory stimuli","volume":"299","author":"Lamon","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.vph.2021.106880_bb0270","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/00004872-200206000-00024","article-title":"Inhibition of mitogen-activated protein\/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats","volume":"20","author":"Touyz","year":"2002","journal-title":"J. Hypertens."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189121000525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189121000525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:20:45Z","timestamp":1761528045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189121000525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":54,"alternative-id":["S1537189121000525"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2021.106880","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic cyclooxygenase-2 inhibition prevents the worsening of hypertension and endothelial dysfunction induced by ouabain in resistance arteries of spontaneously hypertensive rats","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2021.106880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106880"}}